(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-29 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 276333
| Date | Daily Closing Price | Open | High | Low | Volume |
| 29 Mon Jul 2024 | 134.25 | 133.75 | 135.55 | 132.56 | 0.562 times |
| 26 Fri Jul 2024 | 133.75 | 135.48 | 136.36 | 132.99 | 0.636 times |
| 25 Thu Jul 2024 | 134.38 | 133.97 | 136.41 | 133.91 | 0.643 times |
| 24 Wed Jul 2024 | 134.01 | 134.35 | 135.50 | 132.46 | 0.654 times |
| 23 Tue Jul 2024 | 134.76 | 136.26 | 136.59 | 133.95 | 0.81 times |
| 22 Mon Jul 2024 | 136.32 | 135.67 | 137.62 | 134.55 | 1.03 times |
| 19 Fri Jul 2024 | 135.21 | 137.25 | 137.25 | 132.59 | 1.511 times |
| 18 Thu Jul 2024 | 136.52 | 139.47 | 141.46 | 135.13 | 0.935 times |
| 17 Wed Jul 2024 | 138.57 | 139.01 | 140.30 | 135.77 | 0.795 times |
| 16 Tue Jul 2024 | 140.80 | 138.07 | 142.21 | 138.02 | 1.802 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 134.2 as stoploss in an intra day buy trade for a target of 136. However, stock will show a bearish move below 134.2.
Share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Target | 116.63 |
| Downside Target | 121.07 |
| Downside Target | 132.27 |
| Upside Target | 140.09 |
| Upside Target | 140.87 |
| Upside Target | 142.21 |
| Upside Target | 143.20 |
| Upside Target | 143.99 |
| Upside Target | 155.00 |
| Upside Target | 156.84 |
Intraday share price targets for Ascendis Pharma (ASND)
| Target Type | Value |
| Downside Intraday Target | 132.69 |
| Downside Intraday Target | 131.13 |
| Upside Intraday Target | 135.68 |
| Upside Intraday Target | 137.11 |
| Downside Intraday Target | 134.12 |
Weekly technical analysis of Ascendis Pharma (ASND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 29 Mon Jul 2024 | 134.25 | 133.75 | 135.55 | 132.56 | 0.149 times |
| 26 Fri Jul 2024 | 133.75 | 135.67 | 137.62 | 132.46 | 0.606 times |
| 19 Fri Jul 2024 | 135.21 | 138.91 | 142.21 | 132.59 | 1.122 times |
| 12 Fri Jul 2024 | 138.08 | 136.29 | 140.87 | 134.74 | 6.012 times |
| 05 Fri Jul 2024 | 135.81 | 136.06 | 136.78 | 132.38 | 0.419 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 29 Mon Jul 2024 | 134.25 | 135.68 | 142.21 | 132.27 | 0.904 times |
| 28 Fri Jun 2024 | 136.38 | 135.44 | 140.09 | 121.07 | 0.517 times |
| 31 Fri May 2024 | 135.10 | 137.81 | 143.99 | 116.63 | 1.736 times |
| 30 Tue Apr 2024 | 138.44 | 151.07 | 156.84 | 133.39 | 1.165 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
Ascendis Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 136.49 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Ascendis Pharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Ascendis Pharma in short term but the sell signal is initial and weak.
Ascendis Pharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Ascendis Pharma in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 136.49 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.